Skip to main content
Clinical Trials/NL-OMON37132
NL-OMON37132
Completed
Phase 3

The value of Platelet-Rich Plasma injections in the treatment of the jumper's knee: a double-blind randomised trial - PRP for the jumper's knee

Meander Medisch Centrum0 sites90 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
jumper's knee and apexitis
Sponsor
Meander Medisch Centrum
Enrollment
90
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Meander Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • \- pain at the inferior pole of the patella for 3 months
  • \- age 18\-55 year
  • \- tendinosis or thickening compared with the contralateral side of \> 3 mm, detected with ultrasonography or MRI
  • \- already undergone eccentric training for 6 weeks following a standardised protocol

Exclusion Criteria

  • \- pregnancy
  • \- injection in the patellar tendon in the last 3 months, irrespective of the applied substance
  • \- operations on the patellar tendon in the past
  • \- calcifications in the proximal patellar tendon
  • \- at examination indications for intraarticular pathology or patellofemoral pain syndrome
  • \- chronic NSAID use in the past 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials